Lien Gheyle

455 citations

19 papers · 283 indexed · h-index 8

Co-authors: Steven Ramael Graeme L. Fraser Hamid R. Hoveyda Jean Combalbert Ivo Sonderegger Niklas Czeloth Benjamin Lang R. B. Ellis‐Pegler
Topics: Rheumatoid Arthritis Research and Therapies (5 papers)Chronic Lymphocytic Leukemia Research (3 papers)Psoriasis: Treatment and Pathogenesis (3 papers)
Cited by: Reproductive Medicine Immunology Internal Medicine
Journals: Circulation The Journal of Clinical Endocrinology & Metabolism Cancer Research
Partner nations: United States Belgium United Kingdom

In The Last Decade

Lien Gheyle

19 papers receiving 280 citations

Peers

Countries citing papers authored by Lien Gheyle

Since Specialization

Citations

This map shows the geographic impact of Lien Gheyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lien Gheyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lien Gheyle more than expected).

Fields of papers citing papers by Lien Gheyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lien Gheyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lien Gheyle. The network helps show where Lien Gheyle may publish in the future.

Co-authorship network of co-authors of Lien Gheyle

This figure shows the co-authorship network connecting the top 25 collaborators of Lien Gheyle. A scholar is included among the top collaborators of Lien Gheyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lien Gheyle. Lien Gheyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	POS1049 EFFECT OF FILGOTINIB ON PASDAS: DRIVERS OF LOW AND VERY LOW ACTIVITY UP TO WEEK 100 2021 ·Annals of the Rheumatic Diseases ·Laura C. Coates,(unknown),Philip Helliwell,Filip Van den Bosch,Madhukar H. Trivedi,(unknown),(unknown),R. Besuyen,Lien Gheyle,(unknown),Dafna D. Gladman	1
2	POS1038 THE EFFECT OF FILGOTINIB ON ENTHESITIS: 100-WEEK DATA FROM AN OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS 2021 ·Annals of the Rheumatic Diseases ·Philip Helliwell,Laura C. Coates,Filip Van den Bosch,Dafna D. Gladman,Lien Gheyle,Madhukar H. Trivedi,(unknown),(unknown),R. Besuyen,(unknown)	1
3	POS0526 SEXUAL FUNCTION IN MALE AND FEMALE PATIENTS WITH RHEUMATOID ARTHRITIS: A POST-HOC ANALYSIS OF THE FINCH STUDIES 2021 ·Annals of the Rheumatic Diseases ·Luis Fernando Pérez-García,Mihaela Micu,Lien Gheyle,Zhicong Yin,YingMeei Tan,(unknown),(unknown),Katrien Van Beneden,Radboud J. E. M. Dolhain,René Westhovens	1
4	FRI0344 THE LONG-TERM EFFECT OF TREATING PSORIATIC ARTHRITIS WITH THE JANUS KINASE 1-SELECTIVE INHIBITOR FILGOTINIB ON LIPID PROFILES: AN ANALYSIS OF THE EQUATOR AND EQUATOR2 TRIALS 2020 ·Annals of the Rheumatic Diseases ·M. Elaine Husni,Dafna D. Gladman,Philip Helliwell,Filip Van den Bosch,Chantal Tasset,Luc Meuleners,(unknown),Lien Gheyle,Madhukar H. Trivedi,(unknown),R. Besuyen,Philip J. Mease	2
5	FRI0339 LONG-TERM EFFICACY OF THE ORAL SELECTIVE JANUS KINASE 1 INHIBITOR FILGOTINIB IN PSORIATIC ARTHRITIS: WEEK 52 RESPONSE PATTERNS IN INDIVIDUAL PATIENTS FROM AN OPEN-LABEL EXTENSION (OLE) STUDY (EQUATOR2) 2020 ·Annals of the Rheumatic Diseases ·Dafna D. Gladman,Laura C. Coates,Filip Van den Bosch,Philip Helliwell,Chantal Tasset,Luc Meuleners,(unknown),Lien Gheyle,Madhukar H. Trivedi,(unknown),R. Besuyen,(unknown)	2
6	FRI0343 EFFICACY AND SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: SUBGROUP ANALYSES FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL (EQUATOR) 2020 ·Annals of the Rheumatic Diseases ·Philip Helliwell,Filip Van den Bosch,Laura C. Coates,Dafna D. Gladman,Chantal Tasset,Luc Meuleners,(unknown),Lien Gheyle,Madhukar H. Trivedi,(unknown),R. Besuyen,Philip J. Mease	3
7	Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans 2019 ·Vaccine ·Wivine Burny,Arnaud Marchant,Caroline Hervé,Andrea Callegaro,(unknown),Laurence Fissette,Lien Gheyle,Catherine Legrand,Cheikh Ndour,Fernanda Tavares Da Silva,Robbert van der Most,Fabienne Willems,Arnaud M. Didierlaurent,Juan Pablo Yarzábal	51
8	A phase I, randomized, proof‐of‐clinical‐mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteers 2017 ·Human Psychopharmacology Clinical and Experimental ·(unknown),Viktoria Moschetti,C. Dansirikul,(unknown),Lien Gheyle,Frank Runge,Heike Zimdahl‐Gelling,Michael Sand	24
9	Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects 2016 ·Expert Opinion on Investigational Drugs ·Christopher Wynne,(unknown),Ivo Sonderegger,Lien Gheyle,R. B. Ellis‐Pegler,(unknown),Benjamin Lang,Deepak Assudani,(unknown),Niklas Czeloth	50
10	P612. Human safety, pharmacokinetics and pharmacodynamics of the GPR84 antagonist GLPG1205, a potential new approach to treat IBD. 2015 ·Journal of Crohn s and Colitis ·Frédéric Vanhoutte,Sonia Dupont,(unknown),(unknown),Roland Blanqué,Reginald Brys,N. Vandeghinste,Lien Gheyle,Wouter Haazen,Gerben van ‘t Klooster,Johan Beetens	3
11	Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo‐Controlled Studies in Healthy Volunteers 2015 ·Clinical Pharmacology in Drug Development ·Veit J. Erpenbeck,Eva Vets,Lien Gheyle,(unknown),Michael Larbig,(unknown),David A. Sandham,Gerald Dubois,(unknown),Paul Goldsmith,H. Weiss	22
12	A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone 2015 ·Therapeutic Advances in Drug Safety ·Arthur A. Simen,Cynthia Gargano,Jang‐Ho Cha,(unknown),An Bautmans,Ingeborg Heirman,Tine Laethem,(unknown),Lien Gheyle,(unknown),Chan Beals,Aubrey Stoch,Gary G. Kay,Arie Struyk	16
13	The NK3 Receptor Antagonist ESN364 Suppresses Sex Hormones in Men and Women 2015 ·The Journal of Clinical Endocrinology & Metabolism ·Graeme L. Fraser,Steven Ramael,Hamid R. Hoveyda,Lien Gheyle,Jean Combalbert	59
14	Favorable human safety, pharmacokinetics and pharmacodynamics of the autotaxin inhibitor GLPG1690, a potential new treatment in COPD 2015 ·Ellen van der Aar,(unknown),Julie Desrivot,Sonia Dupont,Bertrand Heckmann,Roland Blanqué,Lien Gheyle,Jovica Ralić,Frédéric Vanhoutte	6
15	Safety, tolerability and pharmacokinetics of an oral competitive reversible CRTh2 antagonist, QAW039, in healthy subjects 2014 ·European Respiratory Journal ·Veit J. Erpenbeck,Eva Vets,Lien Gheyle,(unknown),Michael Larbig,(unknown),Gerald Dubois,(unknown)	3
16	Effect of fermented milk containing Lactobacillus casei strain Shirota on constipation-related symptoms and haemorrhoids in women during puerperium 2014 ·Beneficial Microbes ·Tatsuo Sakai,Hiroyuki Kubota,(unknown),Lien Gheyle,Steven Ramael,K Oishi	19
17	Abstract 18403: Effect of Dabigatran on the Ability to Generate Fibrin at a Wound site and its Reversal by Idarucizumab, the Antidote to Dabigatran, in Healthy Volunteers: An Exploratory Marker of Blood Loss 2014 ·Circulation ·Joanne van Ryn,(unknown),(unknown),Lien Gheyle,(unknown),Viktoria Moschetti,Stephan Glund,Paul Reilly,Joachim Stangier	15
18	802 SAFETY AND EFFICACY OF NCX 6560 A NITRIC OXIDE (NO)- DONATING ATORVASTATIN IN A FIRST-INTO-MAN RANDOMISED DOUBLE-BLIND PLACEBO- AND ACTIVE-CONTROLLED STUDY 2011 ·Atherosclerosis Supplements ·P. Pfister,Jacques Djian,(unknown),(unknown),(unknown),(unknown),Lien Gheyle,(unknown)	2
19	Abstract 1568: GLPG0187, a small molecule integrin antagonist, shows good safety and decrease in CTX levels in single ascending dose study 2010 ·Cancer Research ·Giocondo Lorenzon,Lien Gheyle,Eva Vets,Florence Namour,Philippe Pujuguet,Philippe Clément-Lacroix,Piet Wigerinck,Frédéric Vanhoutte	3

About Lien Gheyle

Lien Gheyle is a scholar working on Rheumatology, Gastroenterology and Genetics, having authored 19 papers that have together received 283 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). The work is most often cited by research in Reproductive Medicine (43 citations), Immunology (90 citations) and Internal Medicine (11 citations). Lien Gheyle has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Steven Ramael, Graeme L. Fraser, Hamid R. Hoveyda, Jean Combalbert, Ivo Sonderegger, Niklas Czeloth, Benjamin Lang, R. B. Ellis‐Pegler, Viktoria Moschetti and Christopher Wynne. Their work appears in journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact